GlycoMimetics
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.About GLYC
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.
CEOHarout Semerjian
CEOHarout Semerjian
Employees52
Employees52
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2003
Founded2003
Employees52
Employees52
GLYC Key Statistics
Market cap153.08M
Market cap153.08M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.40M
Average volume1.40M
High today$3.02
High today$3.02
Low today$2.85
Low today$2.85
Open price$2.87
Open price$2.87
Volume796.95K
Volume796.95K
52 Week high$3.60
52 Week high$3.60
52 Week low$0.51
52 Week low$0.51
GLYC News
Simply Wall St 2d
Will GlycoMimetics Spend Its Cash Wisely? - Simply Wall StEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. Indeed, GlycoMimetics ( ) sto...
GLYC Earnings
-$0.34
-$0.23
-$0.11
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 2, Pre-Market
ActualExpected Mar 2, Pre-Market